Acute Respiratory Distress Syndrome Pipeline Report 2024: Insight Encompasses Over 50 Companies and Drug Profiles
27 févr. 2024 11h07 HE
|
Research and Markets
Dublin, Feb. 27, 2024 (GLOBE NEWSWIRE) -- The "Acute Respiratory Distress Syndrome - Pipeline Insight, 2024" report has been added to ResearchAndMarkets.com's offering. Understanding the rapid...
Alpha-1 Antitrypsin Deficiency (AATD) Epidemiology Forecast to 2032 Across the 7MM
29 janv. 2024 12h07 HE
|
Research and Markets
Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The "Alpha-1 Antitrypsin Deficiency - Epidemiology Forecast to 2032" report has been added to ResearchAndMarkets.com's offering. This research offers a...
Levofloxacin Market Forecast Reveals Rapid Growth in Asia-Pacific Region and Advancements in Targeted Therapies
29 janv. 2024 11h15 HE
|
Research and Markets
Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The "Levofloxacin Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. Global attention turns to the recent...
Chronic Obstructive Pulmonary Disease (COPD) Global Clinical Trials Review, 2023: High-Level Data, Leading Companies, Trial Outcomes, Enrollment Trends, and Latest Developments
25 janv. 2024 08h19 HE
|
Research and Markets
Dublin, Jan. 25, 2024 (GLOBE NEWSWIRE) -- The "Chronic Obstructive Pulmonary Disease (COPD) - Global Clinical Trials Review, 2023" report has been added to ResearchAndMarkets.com's offering. This...
Global Idiopathic Pulmonary Fibrosis (IPF) Market Report 2024-2034: IPF Industry to Observe Robust Expansion with Emerging Therapies and Increasing Prevalence of Cough-Related IPF
25 janv. 2024 07h29 HE
|
Research and Markets
Dublin, Jan. 25, 2024 (GLOBE NEWSWIRE) -- The "Cough in Idiopathic pulmonary fibrosis (IPF) - Market Insights, Epidemiology, and Market Forecast - 2034" report has been added to ...
Dry Powder Inhaler Devices Pipeline Analysis Report 2023: Stages of Development, Regulatory Pathways, Key Companies, Regional Insights
24 janv. 2024 04h59 HE
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Dry Powder Inhaler Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies" report has been added to ...
Global Cystic Fibrosis Lung Disease Market Forecasts Promising Growth with Advances in Therapeutics to 2029
08 janv. 2024 13h08 HE
|
Research and Markets
Dublin, Jan. 08, 2024 (GLOBE NEWSWIRE) -- The "Global Cystic Fibrosis Lung Disease Market: Analysis By Drug Type, Route of Administration, Distribution Channel, By Region, By Country: Market...
PULMOZYME (Dornase Alfa) Drug Insights and Market Forecasts, 2019-2022 and 2023-2032: Focus on 7MM - United States, Germany, France, Italy, Spain, United Kingdom and Japan
14 déc. 2023 10h23 HE
|
Research and Markets
Dublin, Dec. 14, 2023 (GLOBE NEWSWIRE) -- The "PULMOZYME Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides comprehensive...
Omalizumab (Xolair) Biosimilars & Biosuperiors Pipeline Review 2023
14 déc. 2023 05h48 HE
|
Research and Markets
Dublin, Dec. 14, 2023 (GLOBE NEWSWIRE) -- The "Omalizumab (Xolair) Biosimilars & Biosuperiors Pipeline Review" report has been added to ResearchAndMarkets.com's offering.This product provides...
Cystic Fibrosis (CF) Therapeutics Global Research Report 2023: Market to Reach $10.11 Billion in 2027 - Long-term Forecast to 2032
29 nov. 2023 10h33 HE
|
Research and Markets
Dublin, Nov. 29, 2023 (GLOBE NEWSWIRE) -- The "Cystic Fibrosis (CF) Therapeutics Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering.The global cystic fibrosis...